Clinical Trials Directory

Trials / Unknown

UnknownNCT04909957

Prediction of Lymph Node Invasion for Prostate Adenocarcinoma

Prediction of Lymph Node Invasion in Patients Operated on for Prostate Adenocarcinoma

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
University Hospital, Brest · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Despite lymph node involvement (LNI) being one of the main prognostic factors in patients with prostate cancer (PCa), pelvic lymph node irradiation remains debated, possibly due to an insufficient selection of patients. Significant advances in LNI risk modelling have been achieved with the addition of visual interpretation of magnetic resonance imaging (MRI) data, but it is likely that quantitative analysis could further improve prediction models. In this study, the investigators aimed to develop and internally validate a novel LNI risk prediction model based on radiomic features extracted from pre-operative multimodal MRI.

Conditions

Timeline

Start date
2021-01-01
Primary completion
2022-11-30
Completion
2022-11-30
First posted
2021-06-02
Last updated
2022-01-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04909957. Inclusion in this directory is not an endorsement.